R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells (Q40191043)
Jump to navigation
Jump to search
scientific article published on 22 December 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells |
scientific article published on 22 December 2006 |
Statements
1 reference
R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells (English)
1 reference
Rolf Larsson
1 reference
Elin Lindhagen
1 reference
Sara Nissle
1 reference
Lorenzo Leoni
1 reference
Gary Elliott
1 reference
Qi Chao
1 reference
Anna Aleskog
1 reference
22 December 2006
1 reference
1 reference
60
1 reference
4
1 reference
545-553
1 reference
Identifiers
1 reference
1 reference